text: Autoimmune Disease Market Reports, focus on Brain Cancer
  Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H2 2018 Summary Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) pipeline Target constitutes close to 21 molecules....
  It has collaboration with various pharmaceutical companies, to develop its product candidates through its GLAAS platform for the treatment of infectious disease, allergy and autoimmune diseases.
  Deciphera Pharmaceuticals products are used in the treatment of renal and colon cancers, mastocytosis, gastrointestinal stromal tumors, crohn' s disease and autoimmune nephritis, solid tumors, rheumatoid arthritis, and others.
  265 pages • By Global Markets Direct • May 2018
  Over a ## month follow-up, ## (##%) patients had stable disease and six (##%) had progressive disease.
  It focuses on therapy areas such as respiratory, inflammation, autoimmune disease (RIA); cardiovascular and metabolic disease (CVMD); and cancer, besides infection and AZN PARTNER ##: ASTRAZENECA PLC COMPANY INFORMATION: PARTNERS Industry neurological
  It develops products for the treatment of cancer, autoimmune diseases, multiple sclerosis, and post-operative pain therapeutics.
  The best overall response was one partial response and one stable disease in these three patients.
  PONTINE GLIOMA - PIPELINE BY MIDATECH PHARMA PLC, H2 2017
  PONTINE GLIOMA - PIPELINE BY MEDICENNA THERAPEUTICS CORP, H2 2017
  The collaboration calls for scientists at Rockefeller to use Hemogenyx' s new type of humanized mice for autoimmune disease modelling in an effort to develop new treatments for autoimmune diseases, specifically lupus.
  Sorrento Therapeutics Inc (STI), formerly QuikByte Software Inc is a biopharmaceutical company that develops novel treatments for cancer, inflammation and autoimmune diseases.
  RECURRENT GLIOBLASTOMA MULTIFORME (GBM) - PIPELINE BY KARYOPHARM THERAPEUTICS, INC., H1 2016
  It offers prescription medicines for treating cardiovascular, metabolic, respiratory, cancer, inflammation, autoimmune, infection and neuroscience diseases.
  311 pages • By Global Markets Direct • Oct 2015
  Brain Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct's, 'Brain Cancer - Pipeline Review, H2 2015', provides an overview of the Brain Cancer's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain Cancer, complete with comparative analysis...
  Its pipeline of SINE compounds also intended for the treatment of viral indications, wound-healing, neurological disorders, inflammation and autoimmune diseases.